Parkwalk Advisors

Oxford Endovascular is focused on developing an innovative medical device for the treatment of brain aneurysms. The company's technology employs a laser-cut metal alloy with shape-memory properties, which can be inserted into a patient's brain via a catheter. Once in place, the device expands into a tiny mesh tube, known as a flow diverter, that conforms to the natural shape of the blood vessel. This design effectively diverts blood flow away from the aneurysm, facilitating its healing and reducing the risk of rupture. By utilizing advanced origami engineering, Oxford Endovascular aims to enhance patient outcomes and improve survival rates for those affected by intracranial aneurysms.

Opsydia Limited specializes in innovative laser marking technology that enables the creation of invisible structures within transparent materials. Founded in 2017 and based in Begbroke, United Kingdom, the company’s technology allows for the permanent and inimitable marking of serial numbers, images, and cryptographic data without altering the surface or compromising the integrity of materials like diamonds, glass, and polymers. This capability positions Opsydia to significantly enhance security and authenticity in various industries, particularly in diamond trading where identity verification is crucial. By embedding marks that are not visible to the naked eye, Opsydia's solutions provide a unique advantage in safeguarding valuable assets and improving overall material quality.

Oxford Endovascular is focused on developing an innovative medical device for the treatment of brain aneurysms. The company's technology employs a laser-cut metal alloy with shape-memory properties, which can be inserted into a patient's brain via a catheter. Once in place, the device expands into a tiny mesh tube, known as a flow diverter, that conforms to the natural shape of the blood vessel. This design effectively diverts blood flow away from the aneurysm, facilitating its healing and reducing the risk of rupture. By utilizing advanced origami engineering, Oxford Endovascular aims to enhance patient outcomes and improve survival rates for those affected by intracranial aneurysms.

Oxford Endovascular is focused on developing an innovative medical device for the treatment of brain aneurysms. The company's technology employs a laser-cut metal alloy with shape-memory properties, which can be inserted into a patient's brain via a catheter. Once in place, the device expands into a tiny mesh tube, known as a flow diverter, that conforms to the natural shape of the blood vessel. This design effectively diverts blood flow away from the aneurysm, facilitating its healing and reducing the risk of rupture. By utilizing advanced origami engineering, Oxford Endovascular aims to enhance patient outcomes and improve survival rates for those affected by intracranial aneurysms.

Oxa is a developer of autonomous vehicle software that focuses on creating AI-based platforms for the operation and scaling of fleets of autonomous vehicles. The company's technology combines laser vision and radar for effective localization, allowing autonomous systems to understand their surroundings and navigate safely in complex environments. Oxa's software is designed to operate with low compute power requirements, making it accessible for various business applications. By providing solutions that enhance vehicle positioning and movement prediction, Oxa enables clients to implement and accelerate the deployment of autonomous vehicles in a range of settings.

Oxa is a developer of autonomous vehicle software that focuses on creating AI-based platforms for the operation and scaling of fleets of autonomous vehicles. The company's technology combines laser vision and radar for effective localization, allowing autonomous systems to understand their surroundings and navigate safely in complex environments. Oxa's software is designed to operate with low compute power requirements, making it accessible for various business applications. By providing solutions that enhance vehicle positioning and movement prediction, Oxa enables clients to implement and accelerate the deployment of autonomous vehicles in a range of settings.

Opsydia Limited specializes in innovative laser marking technology that enables the creation of invisible structures within transparent materials. Founded in 2017 and based in Begbroke, United Kingdom, the company’s technology allows for the permanent and inimitable marking of serial numbers, images, and cryptographic data without altering the surface or compromising the integrity of materials like diamonds, glass, and polymers. This capability positions Opsydia to significantly enhance security and authenticity in various industries, particularly in diamond trading where identity verification is crucial. By embedding marks that are not visible to the naked eye, Opsydia's solutions provide a unique advantage in safeguarding valuable assets and improving overall material quality.

Oxford Endovascular is focused on developing an innovative medical device for the treatment of brain aneurysms. The company's technology employs a laser-cut metal alloy with shape-memory properties, which can be inserted into a patient's brain via a catheter. Once in place, the device expands into a tiny mesh tube, known as a flow diverter, that conforms to the natural shape of the blood vessel. This design effectively diverts blood flow away from the aneurysm, facilitating its healing and reducing the risk of rupture. By utilizing advanced origami engineering, Oxford Endovascular aims to enhance patient outcomes and improve survival rates for those affected by intracranial aneurysms.

Oxford Endovascular is focused on developing an innovative medical device for the treatment of brain aneurysms. The company's technology employs a laser-cut metal alloy with shape-memory properties, which can be inserted into a patient's brain via a catheter. Once in place, the device expands into a tiny mesh tube, known as a flow diverter, that conforms to the natural shape of the blood vessel. This design effectively diverts blood flow away from the aneurysm, facilitating its healing and reducing the risk of rupture. By utilizing advanced origami engineering, Oxford Endovascular aims to enhance patient outcomes and improve survival rates for those affected by intracranial aneurysms.

Reduse Limited provides print removal services from paper using laser technology. Founded in 2015 by David Leal-Ayala, Hidde-Jan Lemstra, and Stuart Evans, the company is headquartered in Cambridge, United Kingdom. Reduse focuses on innovative solutions for recycling and reusing paper materials, offering a sustainable alternative to traditional methods of handling printed paper waste.